The global infectious disease treatment market is projected to grow from $72.5 billion in 2025 to $101 billion by 2030, with a CAGR of 6.9%. Driven by ongoing health challenges, emerging trends ...

Our forward-thinking panel of local leaders will discuss the vision for Tri-Valley, a thriving Bay Area innovation hub. The ...

AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...

The Buckeye Flame's one-stop guide to health insurance for LGBTQ+ Ohioans — from basic terminology to trans-specific tips on ...

BMO Capital keeps an Outperform rating Gilead (GILD) after the Wall Street Journal reported that Robert F. Kennedy Jr. plans ...